What is the ‘Transferred Date’ field in OnCore?

-

The ‘Transferred Date’  field is located on ‘On Study’ tab of a patient record.  This field is used when a patient who was enrolled on the same protocol at another institution was transferred to Stanford to complete the study in our facilities.  When a patient transferred out of Stanford or transferred another research protocol, the ‘Transferred Date’  field should remain blank. 

Multi Race Information from EPIC

-

Our NCI Grant requires us to provide information on our patient population to illustrate that we are serving a broad population.  Ethnicity and Race are such population characteristics therefore having the correct information in OnCore is required. 

On Feb 13, 2020, OnCore started to receive multiple values for participant’s race.  In the past, only the 1st captured information was passed from EPIC to OnCore.  Now, for patient who is self-identified as a person of multi race, all of the race information are sent to OnCore from both SHC and LPCH.  Please still ask the patient to verify his/her race and ethnicity using ‘NCI Ethnicity and Race Classification’ document located in the Forms section of the Coordinator Corner at the time of the consent.  If the information is incorrect in OnCore, please correct it on the patient’s demographic page.

OnCore System Upgrade This Weekend – OnCore will not be available

-

We are upgrading to a new version of OnCore and OnCore will not be available between February 14th 4PM and February 17th 8PM.  After Presidents’ Day, OnCore will look a little different from the current version.    Watch the 5 minute video to learn about changes you’ll notice when using the upgraded OnCore system, including highly recommended action items and verify your browser bookmark to OnCore; it should be “https://oncore.stanford.edu“

Please send your questions to ccto-oncore@stanford.edu.

Modification to OnCore entry of Serious Adverse Events (SAEs) for Industry Sponsored trials

-

Beginning on 25th Nov 2019, CCTO will no longer enter Serious Adverse Events (SAEs) for Industry sponsored trials into OnCore; sending completed SAE form to CCTO-Safety for Industry sponsored trials is no longer required starting November 25th, 2019.

As we are aware, this requires an update to our SOP and guideline documents. The modifications to these documents are in process and they will be shared as soon as they are updated. 

In the meantime, a memo on this decision is posted on the CCTO Regulatory page under Reporting Internal Serious Adverse Events section.

LAST CALL: Upcoming OnCore Advanced Course 07/23/19: “Using OnCore to Answer Questions for Your IRB Continuing Renewal”

-

The topic for the next CCTO OnCore Advanced course has been selected and will be “Using OnCore to Answer Questions for Your IRB Continuing Renewal.”

This course will be held on July 23, 2-4pm at 800 Welch Road, conference room FC380.

If you are interested in taking this optional course, please sign yourself up through STARS by searching the catalog for “CCTO-0025”. Please note that you cannot take an OnCore Advanced course until you have taken the normal Session 4 Cancer OnCore Basic Course.

You can also click on the below Express Link to register:

NOTE: If you sign up for the course and end up not being able to attend, please make sure to either drop the course in STARS yourself, or if you have passed the drop date, email ccto-admin@stanford.edu. We cancel the courses if we do not have above a certain number of attendees, so letting us know when you can’t attend is important.